Clinical Research Directory
Browse clinical research sites, groups, and studies.
Atrophic Age-related Macular Degeneration Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich Plasma
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Summary
The objective of the study will be to evaluate the efficacy of intravitreal injections of Umbilical Cord Blood Platelet-rich Plasma (CB-PRP) in order to reduce or stabilize the atrophic progression in dry Age-related Macular Degeneration (AMD)
Official title: Atrophic Age-related Macular Degeneration (AMD) Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich Plasma (CB-PRP): a Pilot Study
Key Details
Gender
All
Age Range
65 Years - Any
Study Type
INTERVENTIONAL
Enrollment
36
Start Date
2022-12-14
Completion Date
2026-02-10
Last Updated
2025-09-23
Healthy Volunteers
No
Conditions
Interventions
Intravitreal injection of CB-PRP
The procedure consists in a trans-scleral puncture to access the vitreous cavity, with subsequent injection of CB-PRP
Locations (1)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome, Italy